{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T18:14:42Z","timestamp":1771006482586,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.jpba.2011.12.023","type":"journal-article","created":{"date-parts":[[2012,1,29]],"date-time":"2012-01-29T20:02:09Z","timestamp":1327867329000},"page":"53-61","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Solid-state characterization of tacrine hydrochloride"],"prefix":"10.1016","volume":"63","author":[{"given":"Milena","family":"Sorrenti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Catenacci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Bruni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Luppi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Bigucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giampiero","family":"Bettinetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2011.12.023_bib0005","series-title":"Polymorphism in the Pharmaceutical Industry","article-title":"Relevance of solid-state properties for pharmaceutical products","author":"Hilfiker","year":"2006"},{"key":"10.1016\/j.jpba.2011.12.023_bib0010","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1002\/jps.22386","article-title":"Polymorphism and solvatomorphism 2009","volume":"100","author":"Brittain","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2011.12.023_bib0015","doi-asserted-by":"crossref","first-page":"884","DOI":"10.2174\/092986709787549299","article-title":"Polymorphism and crystallization of the active pharmaceutical ingredients (APIs)","volume":"16","author":"Lu","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jpba.2011.12.023_bib0020","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejpb.2008.07.014","article-title":"Solid form screening \u2013 a review","volume":"71","author":"Aaltonen","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jpba.2011.12.023_bib0025","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jpba.2010.12.020","article-title":"An overview of recent studies on the analysis of pharmaceutical polymorphs","volume":"55","author":"Chieng","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2011.12.023_bib0030","series-title":"Polymorphism in the Pharmaceutical Industry","article-title":"The importance of solvates","author":"Griesser","year":"2006"},{"key":"10.1016\/j.jpba.2011.12.023_bib0035","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1023\/A:1016031517430","article-title":"Solid-state characterizations of pharmaceutical hydrates","volume":"68","author":"Giron","year":"2002","journal-title":"J. Therm. Anal. Calorim."},{"key":"10.1016\/j.jpba.2011.12.023_bib0040","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1023\/A:1010159222264","article-title":"Solvent-induced phase transformation of hydrates","volume":"57","author":"Nordhoff","year":"1999","journal-title":"J. Therm. Anal. Calorim."},{"key":"10.1016\/j.jpba.2011.12.023_bib0045","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/jps.20934","article-title":"Relationships between structural and thermal properties of anhydrous and solvated crystalline forms of brodimoprim","volume":"96","author":"Caira","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2011.12.023_bib0050","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1023\/B:JTAN.0000039004.35684.e6","article-title":"Thermal studies of solvent exchange in isostructural solvates of a tetroxoprim\u2013sulfametrole complex","volume":"77","author":"Bettinetti","year":"2004","journal-title":"J. Therm. Anal. Calorim."},{"key":"10.1016\/j.jpba.2011.12.023_bib0055","unstructured":"International Conference on Harmonization (ICH) Guideline Q6A, Test procedures and acceptance criteria for new drug substances and new drug products: chemical substances, vol. 65, Federal Register: December 29, 2000."},{"key":"10.1016\/j.jpba.2011.12.023_bib0060","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1023\/B:JTAN.0000039005.51343.33","article-title":"Solid-state of pharmaceutical compounds. Impact of the ICH Q6 guideline on industrial development","volume":"77","author":"Giron","year":"2004","journal-title":"J. Therm. Anal. Calorim."},{"key":"10.1016\/j.jpba.2011.12.023_bib0065","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3233\/JAD-2006-9S350","article-title":"Tacrine and Alzheimer's treatments","volume":"9","author":"Summers","year":"2006","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jpba.2011.12.023_bib0070","unstructured":"The United States Pharmacopeia Monographs, 34th ed., National Formulary 29, 2011."},{"key":"10.1016\/j.jpba.2011.12.023_bib0075","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0140-6736(95)90526-X","article-title":"Tacrine","volume":"345","author":"Davis","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.jpba.2011.12.023_bib0080","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0378-5173(94)00214-P","article-title":"Transdermal delivery of tacrine: identification of suitable delivery vehicle","volume":"114","author":"Sathyan","year":"1995","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jpba.2011.12.023_bib0085","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1023\/A:1015374600683","article-title":"Transdermal iontophoresis of tacrine in vivo","volume":"19","author":"Kankkunen","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jpba.2011.12.023_bib0090","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1211\/jpp.59.9.0003","article-title":"Nose-to-brain delivery of tacrine","volume":"59","author":"Jogani","year":"2007","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jpba.2011.12.023_bib0095","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ejps.2011.10.002","article-title":"Albumin nanoparticles carrying cyclodextrins for nasal delivery of the anti-Alzheimer drug tacrine","volume":"44","author":"Luppi","year":"2011","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2011.12.023_bib0100","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1107\/S0108270188005384","article-title":"9-Amino-1,2,3,4-tetrahydroacridine hydrochloride monohydrate (THA\u00b7HCl)","volume":"44","author":"Zacharias","year":"1988","journal-title":"Acta Crystallogr. C"},{"key":"10.1016\/j.jpba.2011.12.023_bib0105","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/BF01670205","article-title":"Solid-state structures and conformational studies of four 1,2,3,3-tetrahydroacridine Alzheimer's disease therapeutics","volume":"24","author":"Bandoli","year":"1994","journal-title":"J. Chem. Crystallogr."},{"key":"10.1016\/j.jpba.2011.12.023_bib0110","unstructured":"Handbook of Chemistry and Physics, D.R. Lide, Editor in Chief, 84th ed., CRC Press, 2003\u20132004, section 6."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708511007308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708511007308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T14:31:19Z","timestamp":1583937079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708511007308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":22,"alternative-id":["S0731708511007308"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2011.12.023","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}